First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer
Asher Mullard
Topics & Concepts
AgonistMedicineDrug approvalPharmacologyBladder cancerCancerDrugReceptorInternal medicineImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers